Michael Clarke
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 530th | Aspermont | 28.3% | -26.03% |
| 531st | Cleo Diagnostics | 28.21% | 0% |
| 532nd | Challenger | 28.18% | 17.28% |
| 533rd | GreenX Metals | 27.71% | 27.7% |
| 534th | Famien Resources | 27.71% | 27.7% |
| NEW ROLE: Acting Chief Executive, Funds Management, Challenger | 02 Sep 2022 |
| Position | Company | Year | Company's current rank |
|---|---|---|---|
Acting Chief Executive, Funds Management
|
2021 - 2022 | ||
General Manager, Institutional & Offshore Distribution
|
2013 - 2021 | ||
Director, International & Business Strategy, AMP Capital Investors
|
2004 - 2010 |